Low risk of hemorrhagic complications after obtaining diagnostic skin biopsy specimens in a cohort of thrombocytopenic inpatients - 18/04/17
Doi : 10.1016/j.jaad.2016.12.033
Fan Di Xia a, b, Hasan Khosravi b, Michael A. Waul b, Daniel Butler, MD a, b, Cara Joyce, PhD c, Arash Mostaghimi, MD, MPA, MPH a, b, ⁎ 
a Brigham and Women's Hospital, Boston, Massachusetts
b Harvard Medical School, Boston, Massachusetts
c Loyola University, Chicago, Illinois
∗Reprint requests: Arash Mostaghimi, MD, MPA, MPH, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, PBB-B 421, Boston, MA 02115.Department of DermatologyBrigham and Women's Hospital, Harvard Medical School75 Francis StPBB-B 421BostonMA02115
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Ms Xia and Mr Khosravi contributed equally to this article. |
|
| This study was approved by the Partners Healthcare Institutional Review Board. |
© 2016
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 76 - N° 5
P. 1004-1005 - mai 2017 Retour au numéro
Article précédent
- A review of the impact of patch testing on quality of life in allergic contact dermatitis
- Faustine Ramirez, Mary-Margaret Chren, Nina Botto
- Who wrote this paper? The ethical issues of authorship
- Ammon J. Larsen, Justin Finch, Jane M. Grant-Kels
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?